Trial intelligence / Profile preview

COVIRIC: Viral Load and Immune Responses in RA and SpA Patients with COVID-19

NCT04584541Terminated

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2020
Primary completion
Feb 2022
Countries
1
01

Overview

Trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Detection of SARS-CoV-2 RNA in feces and nasopharyngeal swabs at Day 90, Detection and quantification of IgG, IgM and IgA specific for SARS-CoV-2 N and S proteins in blood at 24 months and 1 more. Started Jun 2020; status: terminated.

Beyond the preview

Go deeper on NCT04584541.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04584541.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call